ArticleJournal of cancer research and clinical oncology2013

Estrogen receptor beta 2 is associated with poor prognosis in estrogen receptor alpha-negative breast carcinoma.

Nuiki Iota Chantzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.